-
Pharmaceutical Compliance Congress: Panelists spot trends to prioritize in 2025
At the annual pharmaceutical compliance event, panelists said the time for an empowered compliance department engaged in mindful monitoring is now.
-
How state regulators are redefining private equity’s role in healthcare
As federal oversight slows, states are steadily reshaping how private equity operates in the sector.
-
Kudman and Posner discuss best practices in healthcare compliance
Our conversation took in good training programs, the OIG’s compliance guidelines, the importance of communication, and more.
-
Attorneys Kudman and Posner on strategies to detect and deter healthcare fraud
We discussed improper marketing strategies, upcoding and billing issues, defense strategies for fraud cases with Tama Kudman and Barry Posner.
-
It’s time for structured oversight of AI in healthcare
How AI and other new technologies present novel compliance and enforcement risks and opportunities to the pharmaceutical industry.
-
Risk as a catalyst: PwC’s Tiffany Gallagher on healthcare compliance innovation
How rapid tech advance has changed healthcare’s compliance landscape.
-
GRIP Extra: SEC Commissioner cautions against rapid deregulation, Greenpeace held liable for $650m
Other news includes the SEC ceasing its defenses of its climate disclosure rule, Fidelity launching its own stablecoin, and UBS limiting its size to skirt capital requirements.
-
Conflicts of interest in healthcare: Aaron Narva explains the tech and the processes
He talks about his AI-powered, data-driven platform and why better management of conflicts of interest can eradicate fraud and overspend.